Dynamic Technology Lab Private Ltd Has $1.19 Million Stake in Inari Medical, Inc. (NASDAQ:NARI)

Dynamic Technology Lab Private Ltd reduced its stake in Inari Medical, Inc. (NASDAQ:NARI) by 31.5% during the fourth quarter, HoldingsChannel reports. The firm owned 23,210 shares of the company’s stock after selling 10,659 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in Inari Medical were worth $1,185,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in NARI. Smartleaf Asset Management LLC lifted its stake in Inari Medical by 128.1% in the 4th quarter. Smartleaf Asset Management LLC now owns 634 shares of the company’s stock valued at $33,000 after purchasing an additional 356 shares during the last quarter. R Squared Ltd bought a new position in shares of Inari Medical in the 4th quarter valued at $45,000. GAMMA Investing LLC boosted its holdings in shares of Inari Medical by 66.8% during the 4th quarter. GAMMA Investing LLC now owns 1,963 shares of the company’s stock valued at $100,000 after acquiring an additional 786 shares in the last quarter. KBC Group NV grew its position in Inari Medical by 31.5% during the 4th quarter. KBC Group NV now owns 2,333 shares of the company’s stock worth $119,000 after acquiring an additional 559 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in Inari Medical by 5.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 2,550 shares of the company’s stock worth $130,000 after purchasing an additional 128 shares in the last quarter. 90.98% of the stock is owned by institutional investors.

Insider Buying and Selling at Inari Medical

In other news, Director William Hoffman sold 200,000 shares of the company’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $60.47, for a total transaction of $12,094,000.00. Following the transaction, the director now owns 238,987 shares in the company, valued at approximately $14,451,543.89. This represents a 45.56 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 10.60% of the company’s stock.

Inari Medical Price Performance

Shares of Inari Medical stock opened at $79.97 on Friday. The stock’s 50-day moving average is $79.91 and its 200 day moving average is $62.64. Inari Medical, Inc. has a one year low of $36.73 and a one year high of $79.99. The firm has a market cap of $4.68 billion, a price-to-earnings ratio of -59.24 and a beta of 1.02.

Analysts Set New Price Targets

NARI has been the topic of several research reports. Oppenheimer began coverage on Inari Medical in a report on Tuesday, December 17th. They set an “outperform” rating and a $75.00 price target on the stock. Canaccord Genuity Group reissued a “hold” rating and set a $80.00 target price (up from $74.00) on shares of Inari Medical in a report on Tuesday, January 7th. Robert W. Baird reaffirmed a “neutral” rating and set a $80.00 price target (down previously from $81.00) on shares of Inari Medical in a research note on Tuesday, January 7th. William Blair reiterated a “market perform” rating on shares of Inari Medical in a report on Tuesday, January 7th. Finally, Baird R W downgraded Inari Medical from a “strong-buy” rating to a “hold” rating in a report on Tuesday, January 7th. Twelve analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Inari Medical currently has an average rating of “Hold” and a consensus price target of $68.00.

About Inari Medical

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.